Abstract
Cancer stem cells contribute to tumor progression, resulting in their capacity to persistently self-renew and propagate tumors. Recent evidence suggests that brain cancer stem cells (BCSCs) are critical for tumor vascular development and therapeutic resistance. Here, we outline the crucial molecular mechanisms and interacting niches involved in BCSCs, which uncovering multiple potential targets for malignant brain tumors and may provide clues for developing novel antibrain tumor treatments.
Original language | English (US) |
---|---|
Pages (from-to) | 84-91 |
Number of pages | 8 |
Journal | BioMedicine (Netherlands) |
Volume | 2 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2012 |
Keywords
- Brain cancer stem cells
- CD133
- Glioblastoma
- Medulloblastomas
- Perivascular niche
- Targeting therapies
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology